Crane et al. [61] have found that genetic or chemical inhibition of Tph1 protects or reverses the development of HFD-induced obesity and dysglycemia via activation of UCP1-mediated thermogenesis. This evidence concerns the gene TPH1 and obesity due to melanocortin 4 receptor deficiency.